THOUSAND OAKS, Calif., May 3, 2012 /PRNewswire/ --Amgen (NASDAQ:AMGN) will present at the Deutsche Bank 37th Annual Healthcare Conference on Tuesday, May 8, 2012, at the InterContinental Hotel, Boston, Mass., beginning at 9:20 a.m. Eastern Daylight Time. Arvind Sood, vice president of Investor Relations at Amgen, will present. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit www.amgen.com. Follow us on www.twitter.com/amgen.
CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Eric Hyllengren, 805-447-1060 (investors)
(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)
SOURCE Amgen
